| Ytd | 4.68% | |
| 1y | 196.11% |
| Open | 18.51 | Prev Close | 18.82 | Low | 18.28 | High | 18.68 | Mkt Cap | 212.56M |
| Vol | 148.00 | Avg Vol | 2.00M | EPS | -5.46 | P/E | -3.45 | Forward P/E | -6.95 |
| Beta | 0.78 | Short Ratio | 5.86 | Inst. Own | 75.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 17.02 | 200-d Avg | 16.32 | 1yr Est | 44.69 |
AVTX News
WAYNE, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical st
WAYNE, Pa. , July 07, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical s
Leerink Partners analyst Thomas Smith initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with
Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to de
WAYNE, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical st
WAYNE, Pa., June 23, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-st
WAYNE, Pa., June 16, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical st
Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's ana
Wall Street analysts upgraded EDU, MKTX, and FORM stocks. Check out their ratings on Benzinga's
Wall Street analysts downgrade ADBE and SAIL, cutting price targets. Check other analysts' views
Top Wall Street analysts changed their outlook on top names. See analyst rating changes for PepsiCo,
WAYNE, PA., May 22, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical sta
Analyst ratings for top names changed: Doximity cut to neutral, National Vision lowered price target
WAYNE, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) (“Avalo”), a cl
Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised
Veeco Instruments Inc (NASDAQ: VECO) rose in pre-market trading after reporting Q1 results and affir
WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a cl
WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a cl
WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical sta
WAYNE, Pa., April 28, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) (“Avalo”), a
Avalo Therapeutics, Inc. (NASDAQ: AVTX - Get Free Report) has been assigned a consensus rating of "M
Wall Street analysts have changed outlooks on top stocks. For details on changes, check out analyst
Pre-Market Stock Futures: Futures are trading mixed as we get ready to kick off the first-quarter ea
Avalo Therapeutics, Inc. (NASDAQ: AVTX - Get Free Report) insider Mittie Doyle sold 679 shares of th
The average of price targets set by Wall Street analysts indicates a potential upside of 113.3% in A
Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, CPRX, TBPH, RLMD and AVTX may p
WAYNE, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) (“Avalo”), a
Ally Bridge Group NY LLC acquired a new position in Avalo Therapeutics, Inc. (NASDAQ: AVTX) in the t
Avalo Therapeutics (NASDAQ: AVTX) CEO Garry Neil said the company expects to report top-line data in
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednes
Tuesday's session saw 211 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.